From the Section of Plastic and Reconstructive Surgery, the Center for Statistical Consultation and Research, and the Department of Radiation Oncology, University of Michigan; and Plastic Surgery, Brigham and Women's Hospital.
Plast Reconstr Surg. 2020 May;145(5):917e-926e. doi: 10.1097/PRS.0000000000006724.
Whether to irradiate the tissue expander before implant exchange or to defer irradiation until after exchange in immediate, two-stage expander/implant reconstruction remains uncertain. The authors evaluated the effects of irradiation timing on complication rates and patient-reported outcomes in patients undergoing immediate expander/implant reconstruction.
Immediate expander/implant reconstruction patients undergoing postmastectomy radiation therapy at 11 Mastectomy Reconstruction Outcomes Consortium sites with demographic, clinical, and complication data were analyzed. Patient-reported outcomes were assessed with BREAST-Q, Patient-Reported Outcomes Measurement Information System, and European Organisation for Research and Treatment of Cancer Breast Cancer-Specific Quality-of-Life Questionnaire surveys preoperatively and 2 years postoperatively. Survey scores and complication rates were analyzed using bivariate comparison and multivariable regressions.
Of 317 patients who met inclusion criteria, 237 underwent postmastectomy radiation therapy before expander/implant exchange (before-exchange cohort), and 80 did so after exchange (after-exchange cohort). Timing of radiation had no significant effect on risks of overall complications (OR, 1.25; p = 0.46), major complications (OR, 1.18; p = 0.62), or reconstructive failure (OR, 0.72; p = 0.49). Similarly, radiation timing had no significant effect on 2-year patient-reported outcomes measured by the BREAST-Q or the European Organisation for Research and Treatment of Cancer survey. Outcomes measured by the Patient-Reported Outcomes Measurement Information System showed less anxiety, fatigue, and depression in the after-exchange group. Compared with preoperative assessments, 2-year patient-reported outcomes significantly declined in both cohorts for Satisfaction with Breasts, Physical Well-Being, and Sexual Well-Being, but improved for anxiety and depression.
Radiation timing (before or after exchange) had no significant effect on complication risks or on most patient-reported outcomes in immediate expander/implant reconstruction. Although lower levels of anxiety, depression, and fatigue were observed in the after-exchange group, these differences may not be clinically significant.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
在即刻、两阶段扩张器/植入物重建中,组织扩张器在植入物更换前进行照射,还是延迟到更换后进行照射仍不确定。作者评估了在接受即刻扩张器/植入物重建的患者中,照射时机对并发症发生率和患者报告的结果的影响。
对 11 个乳房重建结果联合会(Mastectomy Reconstruction Outcomes Consortium)机构的接受乳房切除术放疗的即刻扩张器/植入物重建患者进行了分析,这些患者具有人口统计学、临床和并发症数据。在术前和术后 2 年,使用 BREAST-Q、患者报告的结果测量信息系统(Patient-Reported Outcomes Measurement Information System)和欧洲癌症研究与治疗组织(European Organisation for Research and Treatment of Cancer)乳腺癌特定生活质量问卷(Breast Cancer-Specific Quality-of-Life Questionnaire)调查评估患者报告的结果。使用双变量比较和多变量回归分析调查评分和并发症发生率。
在符合纳入标准的 317 名患者中,237 名患者在扩张器/植入物更换前接受了乳房切除术放疗(前交换队列),80 名患者在更换后接受了放疗(后交换队列)。放疗时机对总体并发症风险(比值比,1.25;p = 0.46)、重大并发症风险(比值比,1.18;p = 0.62)或重建失败风险(比值比,0.72;p = 0.49)均无显著影响。同样,放疗时机对 BREAST-Q 或欧洲癌症研究与治疗组织调查测量的 2 年患者报告结果也没有显著影响。患者报告的结果测量信息系统测量的结果显示,后交换组的焦虑、疲劳和抑郁程度较低。与术前评估相比,两个队列的患者在 2 年时对乳房满意度、身体幸福感和性幸福感的报告结果显著下降,但焦虑和抑郁程度有所改善。
在即刻扩张器/植入物重建中,放疗时机(前交换或后交换)对并发症风险或大多数患者报告的结果均无显著影响。尽管在后交换组中观察到较低水平的焦虑、抑郁和疲劳,但这些差异可能没有临床意义。
临床问题/证据水平:治疗性,II 级。